drugset / Trial / NCT00375739
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
RandomizedSingle-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether topical application of PEP005 is safe for the treatment of actinic keratoses.
Timeline
- Start
- 2006-09
- Primary completion
- 2007-06
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ingenol mebutate | Small molecule | 0.025 % | Topical |
| Subject | ingenol mebutate | Small molecule | 0.05 % | Topical |